In the news release, Infinity To Present At Cantor Fitzgerald Global Healthcare Conference, issued 26-Sep-2018 by Infinity Pharmaceuticals, Inc. over PR Newswire, we are advised by the company that the presentation date and time for the Cantor Fitzgerald Global Healthcare Conference have been updated. The complete, corrected release follows:
CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at Cantor Fitzgerald's Global Healthcare Conference on Tuesday, October 2, 2018, at 5:10 p.m. ET at the Intercontinental New York Barclay Hotel in New York, NY. A live webcast of the presentation will be available on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.
About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:
Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
SOURCE Infinity Pharmaceuticals, Inc.
